First-line therapies in late-onset multiple sclerosis: An Italian registry study.

Aurora ZanghìCarlo AvolioMaria Pia AmatoMassimo FilippiMaria TrojanoFrancesco PattiEmanuele D'Amiconull null

Published in: European journal of neurology (2021)

Real-world data from the Italian MS Register suggested that both injectables and oral first-line DMTs similarly controlled the investigated outcomes in LORRMS.

Keyphrases

late onset
multiple sclerosis
early onset
mass spectrometry
ms ms
white matter
big data
metabolic syndrome
insulin resistance
skeletal muscle
single molecule